CN115553406A - Weight-reducing composition beverage for inhibiting absorption of fat and sugar substances and preparation method thereof - Google Patents
Weight-reducing composition beverage for inhibiting absorption of fat and sugar substances and preparation method thereof Download PDFInfo
- Publication number
- CN115553406A CN115553406A CN202211195423.4A CN202211195423A CN115553406A CN 115553406 A CN115553406 A CN 115553406A CN 202211195423 A CN202211195423 A CN 202211195423A CN 115553406 A CN115553406 A CN 115553406A
- Authority
- CN
- China
- Prior art keywords
- fat
- extract
- absorption
- weight
- inhibiting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000010521 absorption reaction Methods 0.000 title claims abstract description 70
- 239000000203 mixture Substances 0.000 title claims abstract description 58
- 239000000126 substance Substances 0.000 title claims abstract description 49
- 230000002401 inhibitory effect Effects 0.000 title claims abstract description 47
- 235000000346 sugar Nutrition 0.000 title claims abstract description 42
- 235000013361 beverage Nutrition 0.000 title claims abstract description 36
- 238000002360 preparation method Methods 0.000 title claims abstract description 10
- 235000013305 food Nutrition 0.000 claims abstract description 75
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 claims abstract description 32
- 240000008067 Cucumis sativus Species 0.000 claims abstract description 31
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 claims abstract description 31
- 230000002829 reductive effect Effects 0.000 claims abstract description 31
- 240000002853 Nelumbo nucifera Species 0.000 claims abstract description 29
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims abstract description 29
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims abstract description 29
- 244000036905 Benincasa cerifera Species 0.000 claims abstract description 28
- 235000011274 Benincasa cerifera Nutrition 0.000 claims abstract description 28
- 241000219357 Cactaceae Species 0.000 claims abstract description 27
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 22
- 210000003038 endothelium Anatomy 0.000 claims abstract description 22
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 21
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 20
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 20
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 20
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 20
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 20
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 20
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 20
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 20
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 20
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 20
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims abstract description 19
- 229920001100 Polydextrose Polymers 0.000 claims abstract description 16
- 239000001259 polydextrose Substances 0.000 claims abstract description 16
- 235000013856 polydextrose Nutrition 0.000 claims abstract description 16
- 229940035035 polydextrose Drugs 0.000 claims abstract description 16
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 claims abstract description 14
- 239000008395 clarifying agent Substances 0.000 claims abstract description 13
- 239000000796 flavoring agent Substances 0.000 claims abstract description 13
- 235000013355 food flavoring agent Nutrition 0.000 claims abstract description 13
- 239000003925 fat Substances 0.000 claims description 155
- 239000000463 material Substances 0.000 claims description 63
- 239000000284 extract Substances 0.000 claims description 45
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 31
- 238000001556 precipitation Methods 0.000 claims description 24
- 150000001720 carbohydrates Chemical class 0.000 claims description 22
- 239000006228 supernatant Substances 0.000 claims description 21
- 235000006708 antioxidants Nutrition 0.000 claims description 20
- 239000000843 powder Substances 0.000 claims description 19
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 18
- 238000002156 mixing Methods 0.000 claims description 18
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 claims description 17
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims description 17
- 241000512259 Ascophyllum nodosum Species 0.000 claims description 16
- 239000002994 raw material Substances 0.000 claims description 16
- 239000008213 purified water Substances 0.000 claims description 15
- 235000014633 carbohydrates Nutrition 0.000 claims description 14
- 239000000047 product Substances 0.000 claims description 14
- 238000000605 extraction Methods 0.000 claims description 12
- 239000012535 impurity Substances 0.000 claims description 12
- 238000003756 stirring Methods 0.000 claims description 12
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 10
- 244000223760 Cinnamomum zeylanicum Species 0.000 claims description 10
- 235000017803 cinnamon Nutrition 0.000 claims description 10
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 claims description 10
- 238000010438 heat treatment Methods 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 8
- 150000008442 polyphenolic compounds Chemical class 0.000 claims description 8
- 235000013824 polyphenols Nutrition 0.000 claims description 8
- 230000036541 health Effects 0.000 claims description 7
- 239000012528 membrane Substances 0.000 claims description 7
- 238000003860 storage Methods 0.000 claims description 7
- 230000004580 weight loss Effects 0.000 claims description 7
- 244000269722 Thea sinensis Species 0.000 claims description 6
- 235000020230 cinnamon extract Nutrition 0.000 claims description 6
- 238000001816 cooling Methods 0.000 claims description 6
- 239000011550 stock solution Substances 0.000 claims description 6
- 238000001291 vacuum drying Methods 0.000 claims description 6
- 238000005406 washing Methods 0.000 claims description 6
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 5
- 108010024636 Glutathione Proteins 0.000 claims description 5
- 229930003268 Vitamin C Natural products 0.000 claims description 5
- 229960003180 glutathione Drugs 0.000 claims description 5
- 235000020717 hawthorn extract Nutrition 0.000 claims description 5
- 239000002893 slag Substances 0.000 claims description 5
- 235000019154 vitamin C Nutrition 0.000 claims description 5
- 239000011718 vitamin C Substances 0.000 claims description 5
- 229930091371 Fructose Natural products 0.000 claims description 4
- 239000005715 Fructose Substances 0.000 claims description 4
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 4
- 244000068988 Glycine max Species 0.000 claims description 4
- 235000010469 Glycine max Nutrition 0.000 claims description 4
- 229920001542 oligosaccharide Polymers 0.000 claims description 4
- 150000002482 oligosaccharides Chemical class 0.000 claims description 4
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 3
- 108090000145 Bacillolysin Proteins 0.000 claims description 3
- 108010059892 Cellulase Proteins 0.000 claims description 3
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 3
- 239000004386 Erythritol Substances 0.000 claims description 3
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims description 3
- 241000287828 Gallus gallus Species 0.000 claims description 3
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 3
- 229930195725 Mannitol Natural products 0.000 claims description 3
- 102000035092 Neutral proteases Human genes 0.000 claims description 3
- 108091005507 Neutral proteases Proteins 0.000 claims description 3
- 108090000526 Papain Proteins 0.000 claims description 3
- 108010059820 Polygalacturonase Proteins 0.000 claims description 3
- 239000004365 Protease Substances 0.000 claims description 3
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 3
- 235000004279 alanine Nutrition 0.000 claims description 3
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 3
- FYGDTMLNYKFZSV-DZOUCCHMSA-N alpha-D-Glcp-(1->4)-alpha-D-Glcp-(1->4)-D-Glcp Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)O[C@H](O[C@@H]2[C@H](OC(O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-DZOUCCHMSA-N 0.000 claims description 3
- 238000009924 canning Methods 0.000 claims description 3
- 229940106157 cellulase Drugs 0.000 claims description 3
- 238000005352 clarification Methods 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- 235000019414 erythritol Nutrition 0.000 claims description 3
- 229940009714 erythritol Drugs 0.000 claims description 3
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims description 3
- 108010093305 exopolygalacturonase Proteins 0.000 claims description 3
- 235000011194 food seasoning agent Nutrition 0.000 claims description 3
- 239000000845 maltitol Substances 0.000 claims description 3
- 235000010449 maltitol Nutrition 0.000 claims description 3
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 claims description 3
- 229940035436 maltitol Drugs 0.000 claims description 3
- 239000000594 mannitol Substances 0.000 claims description 3
- 235000010355 mannitol Nutrition 0.000 claims description 3
- 229940055729 papain Drugs 0.000 claims description 3
- 235000019834 papain Nutrition 0.000 claims description 3
- 239000001415 potassium malate Substances 0.000 claims description 3
- 238000007873 sieving Methods 0.000 claims description 3
- 235000013616 tea Nutrition 0.000 claims description 3
- 238000000108 ultra-filtration Methods 0.000 claims description 3
- 241001092040 Crataegus Species 0.000 claims 5
- 238000007580 dry-mixing Methods 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 208000016261 weight loss Diseases 0.000 claims 1
- 241000282414 Homo sapiens Species 0.000 abstract description 79
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract description 23
- 235000015097 nutrients Nutrition 0.000 abstract description 21
- 230000029087 digestion Effects 0.000 abstract description 17
- 240000000171 Crataegus monogyna Species 0.000 abstract description 15
- 238000001727 in vivo Methods 0.000 abstract description 11
- 241000186000 Bifidobacterium Species 0.000 abstract description 9
- 235000005911 diet Nutrition 0.000 abstract description 9
- 230000037213 diet Effects 0.000 abstract description 9
- 230000036528 appetite Effects 0.000 abstract description 8
- 235000019789 appetite Nutrition 0.000 abstract description 8
- 210000001596 intra-abdominal fat Anatomy 0.000 abstract description 7
- 239000002207 metabolite Substances 0.000 abstract description 7
- 230000036961 partial effect Effects 0.000 abstract description 7
- 230000035755 proliferation Effects 0.000 abstract description 6
- 239000000295 fuel oil Substances 0.000 abstract description 4
- 150000004676 glycans Chemical class 0.000 abstract description 4
- 210000000936 intestine Anatomy 0.000 abstract description 4
- 229920001282 polysaccharide Polymers 0.000 abstract description 4
- 239000005017 polysaccharide Substances 0.000 abstract description 4
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 abstract description 2
- 235000019197 fats Nutrition 0.000 description 138
- 230000009102 absorption Effects 0.000 description 57
- 230000003405 preventing effect Effects 0.000 description 46
- 230000001737 promoting effect Effects 0.000 description 45
- 210000004369 blood Anatomy 0.000 description 38
- 239000008280 blood Substances 0.000 description 38
- 230000000694 effects Effects 0.000 description 34
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 32
- 208000008589 Obesity Diseases 0.000 description 23
- 235000020824 obesity Nutrition 0.000 description 23
- 238000009825 accumulation Methods 0.000 description 18
- 230000015572 biosynthetic process Effects 0.000 description 17
- 230000001105 regulatory effect Effects 0.000 description 16
- 241000699670 Mus sp. Species 0.000 description 15
- 230000004060 metabolic process Effects 0.000 description 15
- 230000006870 function Effects 0.000 description 14
- 238000003786 synthesis reaction Methods 0.000 description 14
- 210000004185 liver Anatomy 0.000 description 13
- 230000003647 oxidation Effects 0.000 description 13
- 238000007254 oxidation reaction Methods 0.000 description 13
- 235000012000 cholesterol Nutrition 0.000 description 12
- 230000001976 improved effect Effects 0.000 description 12
- 230000001965 increasing effect Effects 0.000 description 12
- 230000000968 intestinal effect Effects 0.000 description 11
- 150000003254 radicals Chemical class 0.000 description 11
- 238000006243 chemical reaction Methods 0.000 description 10
- 201000010099 disease Diseases 0.000 description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- 150000002632 lipids Chemical class 0.000 description 10
- 241000894006 Bacteria Species 0.000 description 9
- 208000024172 Cardiovascular disease Diseases 0.000 description 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 8
- 230000009286 beneficial effect Effects 0.000 description 8
- 238000000354 decomposition reaction Methods 0.000 description 8
- 239000003814 drug Substances 0.000 description 8
- 239000008103 glucose Substances 0.000 description 8
- 230000002040 relaxant effect Effects 0.000 description 8
- 210000001519 tissue Anatomy 0.000 description 8
- 230000002588 toxic effect Effects 0.000 description 8
- 206010010774 Constipation Diseases 0.000 description 7
- 206010020772 Hypertension Diseases 0.000 description 7
- 208000026106 cerebrovascular disease Diseases 0.000 description 7
- 208000029078 coronary artery disease Diseases 0.000 description 7
- 230000012010 growth Effects 0.000 description 7
- 230000028327 secretion Effects 0.000 description 7
- 231100000331 toxic Toxicity 0.000 description 7
- 239000003053 toxin Substances 0.000 description 7
- 231100000765 toxin Toxicity 0.000 description 7
- 108700012359 toxins Proteins 0.000 description 7
- 206010003210 Arteriosclerosis Diseases 0.000 description 6
- 206010003694 Atrophy Diseases 0.000 description 6
- 208000011775 arteriosclerosis disease Diseases 0.000 description 6
- 230000037444 atrophy Effects 0.000 description 6
- 230000008901 benefit Effects 0.000 description 6
- 230000037396 body weight Effects 0.000 description 6
- 210000004556 brain Anatomy 0.000 description 6
- 230000002526 effect on cardiovascular system Effects 0.000 description 6
- 230000002708 enhancing effect Effects 0.000 description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 206010028980 Neoplasm Diseases 0.000 description 5
- 229930006000 Sucrose Natural products 0.000 description 5
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 5
- 210000000577 adipose tissue Anatomy 0.000 description 5
- 210000004204 blood vessel Anatomy 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 230000003203 everyday effect Effects 0.000 description 5
- 230000029142 excretion Effects 0.000 description 5
- 230000002496 gastric effect Effects 0.000 description 5
- 210000004347 intestinal mucosa Anatomy 0.000 description 5
- 210000002429 large intestine Anatomy 0.000 description 5
- 230000014759 maintenance of location Effects 0.000 description 5
- 239000006041 probiotic Substances 0.000 description 5
- 235000018291 probiotics Nutrition 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 239000005720 sucrose Substances 0.000 description 5
- 201000001320 Atherosclerosis Diseases 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 230000000711 cancerogenic effect Effects 0.000 description 4
- 231100000315 carcinogenic Toxicity 0.000 description 4
- 230000002354 daily effect Effects 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 230000001079 digestive effect Effects 0.000 description 4
- 238000007599 discharging Methods 0.000 description 4
- 230000035619 diuresis Effects 0.000 description 4
- 210000003743 erythrocyte Anatomy 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- 150000007524 organic acids Chemical class 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 235000013406 prebiotics Nutrition 0.000 description 4
- 238000010791 quenching Methods 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 230000035922 thirst Effects 0.000 description 4
- 239000003440 toxic substance Substances 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 208000004930 Fatty Liver Diseases 0.000 description 3
- 108010010234 HDL Lipoproteins Proteins 0.000 description 3
- 102000015779 HDL Lipoproteins Human genes 0.000 description 3
- 206010019708 Hepatic steatosis Diseases 0.000 description 3
- 208000002720 Malnutrition Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 102000057297 Pepsin A Human genes 0.000 description 3
- 108090000284 Pepsin A Proteins 0.000 description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
- 230000000903 blocking effect Effects 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 201000001883 cholelithiasis Diseases 0.000 description 3
- 238000002485 combustion reaction Methods 0.000 description 3
- -1 daily catering Chemical class 0.000 description 3
- 238000000151 deposition Methods 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 208000010706 fatty liver disease Diseases 0.000 description 3
- 235000013312 flour Nutrition 0.000 description 3
- 235000001727 glucose Nutrition 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 239000004310 lactic acid Substances 0.000 description 3
- 235000014655 lactic acid Nutrition 0.000 description 3
- 230000001071 malnutrition Effects 0.000 description 3
- 235000000824 malnutrition Nutrition 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 210000003470 mitochondria Anatomy 0.000 description 3
- 230000002107 myocardial effect Effects 0.000 description 3
- 208000015380 nutritional deficiency disease Diseases 0.000 description 3
- 229940111202 pepsin Drugs 0.000 description 3
- 230000035790 physiological processes and functions Effects 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 231100000240 steatosis hepatitis Toxicity 0.000 description 3
- 230000004936 stimulating effect Effects 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 231100000167 toxic agent Toxicity 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 208000007848 Alcoholism Diseases 0.000 description 2
- 206010009944 Colon cancer Diseases 0.000 description 2
- 208000005577 Gastroenteritis Diseases 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 239000004367 Lipase Substances 0.000 description 2
- 102000004882 Lipase Human genes 0.000 description 2
- 108090001060 Lipase Proteins 0.000 description 2
- 208000017170 Lipid metabolism disease Diseases 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 201000002451 Overnutrition Diseases 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 210000000579 abdominal fat Anatomy 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 201000007930 alcohol dependence Diseases 0.000 description 2
- 230000003266 anti-allergic effect Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 238000005842 biochemical reaction Methods 0.000 description 2
- 235000008429 bread Nutrition 0.000 description 2
- 235000019577 caloric intake Nutrition 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 230000000747 cardiac effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 2
- 229960001231 choline Drugs 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 208000029742 colonic neoplasm Diseases 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 238000001784 detoxification Methods 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 235000013325 dietary fiber Nutrition 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 230000037149 energy metabolism Effects 0.000 description 2
- 238000003912 environmental pollution Methods 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 235000019249 food preservative Nutrition 0.000 description 2
- 239000005452 food preservative Substances 0.000 description 2
- 235000021588 free fatty acids Nutrition 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 229910001385 heavy metal Inorganic materials 0.000 description 2
- 208000014617 hemorrhoid Diseases 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 235000019421 lipase Nutrition 0.000 description 2
- 235000019626 lipase activity Nutrition 0.000 description 2
- 230000037356 lipid metabolism Effects 0.000 description 2
- 108010022197 lipoprotein cholesterol Proteins 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 210000004379 membrane Anatomy 0.000 description 2
- 230000007102 metabolic function Effects 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 210000004165 myocardium Anatomy 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 235000020823 overnutrition Nutrition 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- 230000008855 peristalsis Effects 0.000 description 2
- 238000001050 pharmacotherapy Methods 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000000171 quenching effect Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 230000002000 scavenging effect Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 150000005846 sugar alcohols Chemical class 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- 235000019786 weight gain Nutrition 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- BHQCQFFYRZLCQQ-UHFFFAOYSA-N (3alpha,5alpha,7alpha,12alpha)-3,7,12-trihydroxy-cholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 BHQCQFFYRZLCQQ-UHFFFAOYSA-N 0.000 description 1
- RBNPOMFGQQGHHO-UHFFFAOYSA-N -2,3-Dihydroxypropanoic acid Natural products OCC(O)C(O)=O RBNPOMFGQQGHHO-UHFFFAOYSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 229930195730 Aflatoxin Natural products 0.000 description 1
- XWIYFDMXXLINPU-UHFFFAOYSA-N Aflatoxin G Chemical compound O=C1OCCC2=C1C(=O)OC1=C2C(OC)=CC2=C1C1C=COC1O2 XWIYFDMXXLINPU-UHFFFAOYSA-N 0.000 description 1
- 208000022309 Alcoholic Liver disease Diseases 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 235000006008 Brassica napus var napus Nutrition 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- 239000004380 Cholic acid Substances 0.000 description 1
- 235000007106 Crataegus suborbiculata Nutrition 0.000 description 1
- 241000073432 Crataegus suborbiculata Species 0.000 description 1
- RBNPOMFGQQGHHO-UWTATZPHSA-N D-glyceric acid Chemical compound OC[C@@H](O)C(O)=O RBNPOMFGQQGHHO-UWTATZPHSA-N 0.000 description 1
- 101710146739 Enterotoxin Proteins 0.000 description 1
- 235000019733 Fish meal Nutrition 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 208000032139 Halitosis Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 206010019837 Hepatocellular injury Diseases 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 208000005016 Intestinal Neoplasms Diseases 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 208000001145 Metabolic Syndrome Diseases 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000026137 Soft tissue injury Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 240000004429 Tephrosia purpurea Species 0.000 description 1
- 235000017517 Tephrosia purpurea Nutrition 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 235000013202 a hawthorn Nutrition 0.000 description 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000005409 aflatoxin Substances 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 239000002830 appetite depressant Substances 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 238000013542 behavioral therapy Methods 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 229940036811 bone meal Drugs 0.000 description 1
- 239000002374 bone meal Substances 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 229910052793 cadmium Inorganic materials 0.000 description 1
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 230000025938 carbohydrate utilization Effects 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 210000002390 cell membrane structure Anatomy 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 1
- 229960002471 cholic acid Drugs 0.000 description 1
- 235000019416 cholic acid Nutrition 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 239000003026 cod liver oil Substances 0.000 description 1
- 235000012716 cod liver oil Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 235000021403 cultural food Nutrition 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 230000001877 deodorizing effect Effects 0.000 description 1
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000001916 dieting Nutrition 0.000 description 1
- 230000037228 dieting effect Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002888 effect on disease Effects 0.000 description 1
- 210000000750 endocrine system Anatomy 0.000 description 1
- 238000004146 energy storage Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000000147 enterotoxin Substances 0.000 description 1
- 231100000655 enterotoxin Toxicity 0.000 description 1
- 238000009207 exercise therapy Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000004467 fishmeal Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000003086 food stabiliser Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 208000001130 gallstones Diseases 0.000 description 1
- 230000030136 gastric emptying Effects 0.000 description 1
- 230000030135 gastric motility Effects 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 231100000234 hepatic damage Toxicity 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 239000000859 incretin Substances 0.000 description 1
- MGXWVYUBJRZYPE-YUGYIWNOSA-N incretin Chemical class C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)[C@@H](C)O)[C@@H](C)CC)C1=CC=C(O)C=C1 MGXWVYUBJRZYPE-YUGYIWNOSA-N 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 208000028774 intestinal disease Diseases 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 239000010699 lard oil Substances 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 230000004130 lipolysis Effects 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 231100000849 liver cell damage Toxicity 0.000 description 1
- 230000008818 liver damage Effects 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 235000020845 low-calorie diet Nutrition 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 210000001087 myotubule Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 230000000529 probiotic effect Effects 0.000 description 1
- 230000022558 protein metabolic process Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 231100000272 reduced body weight Toxicity 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 230000009278 visceral effect Effects 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 239000013585 weight reducing agent Substances 0.000 description 1
- 235000014101 wine Nutrition 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/60—Sweeteners
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/68—Acidifying substances
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
- A23L33/25—Synthetic polymers, e.g. vinylic or acrylic polymers
- A23L33/26—Polyol polyesters, e.g. sucrose polyesters; Synthetic sugar polymers, e.g. polydextrose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/33—Cactaceae (Cactus family), e.g. pricklypear or Cereus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/62—Nymphaeaceae (Water-lily family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Child & Adolescent Psychology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
- Non-Alcoholic Beverages (AREA)
Abstract
The invention discloses a weight-losing composition beverage for inhibiting fat and sugar substance absorption and a preparation method thereof, wherein the weight-losing composition beverage comprises the following components: cucumber, wax gourd, cactus, lotus leaf, hawthorn, endothelium corneum gigeriae galli, polydextrose, L-arabinose, L-carnitine, antioxidant, flavoring agent and clarifying agent; after the composition is eaten, the appetite is not inhibited, the diet is not required, the food is not limited by the food calorie, the heavy oil polysaccharide food is eaten as long as people want to eat, the digestion of the food and the absorption of nutrient substances are promoted, the partial absorption of fat and sugar substances by a human body is inhibited, the generation of new fat in the body is reduced, the consumption of fat in the human body is accelerated, the visceral fat in the human body is reduced, the proliferation of bifidobacterium in intestinal tracts is promoted, the intestine is loosened, the bowel is relaxed, and in-vivo toxin and metabolite are excreted in time to achieve the purpose of losing weight.
Description
Technical Field
The invention relates to the technical field of food, health-care products and medicines, in particular to a weight-losing composition beverage for inhibiting absorption of fat and sugar substances and a preparation method thereof.
Background
People use food as the day, the food is nutrient substances capable of providing energy and regulating physiological functions for normal operation of a human body, and is the basis of human survival, the food is usually composed of carbohydrate, fat, protein, vitamins, mineral substances and water, the food is called food by cooking, the food culture is profound and profound in the world, the nutrient substances are different, more delicious food is pursued by human, the energy obtained by proper amount of various nutrient substances maintains normal operation of human body, the energy obtained by human exceeds the consumption for maintaining normal operation of human body due to the delicious food, so that energy storage is caused, the food is overnutrition, and the overnutrition is accumulated in the day and the month and causes obesity; obesity: the disease refers to the disease of body weight gain caused by excessive fat deposition in body due to the change of physical and chemical functions, which leads to a series of physiological and pathological changes; the risk of obesity: the diseases such as metabolic syndrome, cardiovascular and cerebrovascular diseases, respiratory system diseases, digestive system and endocrine system functions are influenced, the risk of cancer occurrence is enhanced, the obesity not only influences body beauty, but also brings inconvenience to life, and also can cause joint soft tissue injury, reproductive capacity reduction, mental disorder, stroke, hypertension, coronary heart disease, atherosclerosis, fatty liver, diabetes, gallstone, edema, gout, cancer and the like, so that the obesity is the source of ten thousands of diseases; weight loss is mainly aimed at reducing excess fat and losing weight, and because more than 60% of human bodies are water, the weight can be immediately reduced by promoting the reduction of the body fluid volume, but the loss of the fat volume is very slow, so the weight loss is mainly realized by reducing the excess fat in the body, and the weight loss is not only based on the weight loss but also ensured by absorbing nutrient substances, so that the malnutrition of the weight losers is avoided, and the more harm is caused.
At present, 4 common methods for preventing and treating obesity comprise pharmacotherapy, dietotherapy, exercise therapy and behavioral therapy, and the medicaments with weight-losing effect mainly comprise appetite inhibitors, hormones for accelerating metabolism and certain medicaments, and medicaments for influencing digestive absorption and fat mobilization; although these pharmacotherapies have the effect of losing weight, most of them have certain side effects, and they also need to be matched with low-calorie diet to increase the effect of losing weight, so that the malnutrition of the people who lose weight is easily caused, the desire of the people for delicious food is suppressed, once the people stop losing weight, the desire for delicious food can lead to the continuous increase of the fat of the human body, and the repetition can lead the people to circulate in diet losing weight, regaining weight, diet losing weight and regaining weight, and the people face a difficult choice between the delicious food and the obesity, and the delicious food often accounts for the wind.
The weight-reducing medicines sold in the market basically mainly reduce weight and secondarily reduce fat, and the patent publications basically also mainly reduce weight and secondarily reduce fat, and require eaters to eat diet, reduce calorie intake and suppress appetite, and have no weight-reducing beverage food, health-care product and medicine which can reduce weight, avoid dieting, reduce calorie intake limit, suppress appetite, promote digestion and absorption of food and suppress fat and sugar substances absorbed by human bodies.
According to the theory of homology of medicine and food, the invention selects food and medicinal materials such as cucumber, wax gourd, cactus, lotus leaf, hawthorn, chicken's gizzard-skin and cinnamon from a plurality of food materials and medicinal materials, extracts of the food and medicinal materials are obtained by refining and purifying technology, and the extracts are optimally matched with polydextrose, arabinose and L-carnitine.
Disclosure of Invention
The invention aims to overcome the defects of the prior art and provide a weight-losing composition beverage for inhibiting the absorption of fat and sugar substances and a preparation method thereof, the composition beverage improves the catering modes of heavy oil polysaccharide such as daily catering, business-to-business catering, various party catering, family catering and the like of people in daily life and work, the simple obesity caused by more eating calories than the human body consumption and the weight-losing problem of preventing obese people, the food-saving weight-reducing-dieting-reducing-dieting-regaining repeated by people, the problems of appetite inhibition, diet control and calorie control of people in weight-losing and the malnutrition caused by weight-losing, the obesity caused by diet is reduced as much as possible, the body damage caused by the obesity is alleviated, and the life and life quality and confidence of the part of people are improved.
The purpose of the invention is realized by the following technical scheme:
a slimming composition drink for inhibiting the absorption of fats and saccharides;
the composition beverage comprises the following components: 5-20 kg of cucumber, 5-20 kg of wax gourd, 1-10 kg of cactus, 1-10 kg of lotus leaf, 3-20 kg of polydextrose, 3-20 kg of arabinose, 5-25 kg of L-carnitine, 0-10 kg of hawthorn, 0-10 kg of endothelium corneum gigeriae galli, 1-20 kg of antioxidant, 1-10 kg of flavoring agent and 1-20 kg of clarifying agent.
Further, the flavoring agent is one or more of erythritol, maltitol, malto-oligosaccharide, soybean oligosaccharide, trehalose, mannitol, cinnamon, L-potassium malate, fructose, and alanine.
Further, the clarifying agent is one or more of a kelp extract and papain.
Further, the cucumber, the wax gourd, the cactus, the lotus leaf, the hawthorn, the endothelium corneum gigeriae galli, the kelp and the cinnamon are respectively a cucumber extract, a wax gourd extract, a cactus extract, a lotus leaf extract, a hawthorn extract, an endothelium corneum gigeriae galli extract, a kelp extract and a cinnamon extract.
Further, the antioxidant is a mixture of glutathione, apple polyphenol, vitamin C and tea polyphenol, which is mixed according to a ratio of 1:1 of 8230and 1 of the above-mentioned raw materials.
Furthermore, the composition beverage is used in food, health products and pharmaceutical formulations.
Further, the preparation method of the cucumber extract, the wax gourd extract, the cactus extract, the lotus leaf extract, the hawthorn extract, the chicken's gizzard-membrane extract, the kelp extract and the cinnamon extract comprises the following steps:
step 1, preparing raw materials: cucumber, wax gourd, lotus leaf, cactus, kelp, hawthorn, endothelium corneum gigeriae galli and cinnamon;
step 2, crushing: manually sorting the collected Chinese medicinal raw materials according to varieties, putting into a washing tank, drying to constant weight, crushing to obtain fine powder of the Chinese medicinal raw materials, and sieving by more than 150-200 meshes;
step 3, extraction: conveying the fine powder of the edible and medicinal materials to an extraction tank, adding purified water, and mixing the materials with water 1: 5. keeping the temperature at 65-95 ℃ for 1-3 hours and 3 times, centrifugally separating to obtain supernatant and medicinal fine powder residues, and inputting the supernatant into an alcohol precipitation tank for precipitation;
inputting the fine powder slag of the edible and medicinal materials into an extraction tank, and adding purified water, material water 1:5, PH4.5-6.0, adding pectinase and cellulase, keeping the temperature at 40-45 ℃ for 2-3 hours and 2 times, centrifugally separating to obtain supernatant and medicinal fine powder residues, and inputting the supernatant into an alcohol precipitation tank for precipitation;
inputting the fine powder slag of the edible and medicinal materials into an extraction tank, and adding purified water, material water 1: 3. adding neutral protease at the pH of 6.5-8.0, keeping the temperature at 25-35 ℃ for 2 times for 2-3 hours, centrifuging to obtain supernatant, and inputting the supernatant into an alcohol precipitation tank for precipitation;
and 4, purifying: and (4) concentrating the supernatant precipitated in the alcohol precipitation tank in the step (3) under reduced pressure to 50% of the volume, decoloring, and then performing alcohol precipitation, washing, vacuum drying, dissolving, removing impurities by using an ultrafiltration membrane, and vacuum drying to obtain a finished product of the extract for later use.
A method for preparing a weight-reducing composition beverage for inhibiting the absorption of fats and sugar substances comprises the following steps:
s1, preparing raw materials: 5-20 kg of cucumber, 5-20 kg of wax gourd, 1-10 kg of cactus, 1-10 kg of lotus leaf, 3-20 kg of polydextrose, 3-20 kg of arabinose, 5-25 kg of L-carnitine, 0-10 kg of hawthorn, 0-10 kg of endothelium corneum gigeriae galli, 1-20 kg of antioxidant, 1-10 kg of flavoring agent and 1-20 kg of clarifying agent;
the cucumber, the polydextrose and the arabinose are dry-mixed uniformly to form a material A; mixing radix et caulis Opuntiae Dillenii, L-carnitine, fructus crataegi and folium Nelumbinis, and mixing to obtain material B; mixing fructus Benincasae, endothelium corneum Gigeriae Galli, and antioxidant, and making into No. C material;
s2, preparing materials: conveying purified water to a mixing tank through a pipeline, heating to 30-40 ℃, then conveying the material A, the material B and the material C obtained in the step S1 to the mixing tank through pipelines in sequence, starting stirring, stirring at a low speed for 10-20 min, dissolving and mixing the material liquid in the mixing tank uniformly, and starting a filter to remove impurities;
s3, seasoning: cooling and conveying the material obtained in the step S2 to a quantifying tank, adding purified water for complementing, heating to 30-40 ℃, adding a flavoring agent for dissolving, stirring at a low speed until the mixture is uniformly mixed, and opening a filter to remove impurities;
s4, clarification: adding a clarifying agent into the feed liquid obtained in the step S3 until the feed liquid is dissolved, stirring at a low speed for 5-10 min, heating to 100 ℃, keeping the temperature for 5-10 min, cooling to 0 ℃, keeping the temperature for 10-20 min, opening a filter to remove impurities, and conveying to an aseptic storage tank;
s5, sterile subpackaging: subpackaging the stock solution obtained in the step 4, connecting the stock solution of an aseptic storage tank with a canning machine through a pipeline, carrying out aseptic subpackage to obtain a finished product, and boxing;
and S6, checking.
The invention has the beneficial effects that:
economic and social benefits: if 1% of obese people can achieve the weight-losing purpose, the weight-losing effect of the formula can slow down diseases caused by obesity of the part of people, so that the medical expense is saved, the formula has great economic benefit to society and families, wealth can be continuously created for the society, even immeasurable social benefit can be realized, the diseases caused by obesity mainly refer to cardiovascular and cerebrovascular diseases, if sick people in the families are recovered or relieved, nursed people get rid of the problems, medical insurance payment and family medical expense are saved or reduced, family joy and harmony can be realized, individuals can obtain income and create social wealth;
the medicinal and edible traditional Chinese medicinal materials are purchased from traditional Chinese medicinal material growers, and if the traditional Chinese medicinal materials are sold, the purchase quantity of the traditional Chinese medicinal materials is increased, so that the planting area is enlarged by the growers, the income is increased, and the country employment is promoted; the medicinal material manufacturers and the project can drive employment, which is beneficial to economic development and social employment; the formula is medicinal and edible, the selected purified raw materials of the weight-reducing traditional Chinese medicinal materials are Chinese waxgourd, cucumber, cactus, lotus leaf, kelp, hawthorn and the like, the Chinese waxgourd, cucumber, cactus, lotus leaf, kelp, hawthorn and the like are planted in large area all over the country, the eating mode is mainly daily eating, the food materials are required to reach a certain grade, the commodity specification can be reached, the market is sold, and cucumber, chinese waxgourd, lotus leaf, kelp and hawthorn growers with poorer grades and not reaching the commodity specification can only discard as garbage and can also cause environmental pollution; the large-scale production can be realized, if the food is sold, the purchasing amount of food materials can be increased, the mode of company and industry association plus peasant households or cooperative society is adopted, more employment opportunities can be created for peasant households, remote moving peasant households and returning to the country for creating industry, more peasant households are allowed to participate in the operation, the income is increased, the families are cared for, and the cultivation and increase of food and medicinal material planting are also a mode;
the innovation points of the invention are as follows: the weight-losing beverage is free of sucrose, prebiotics and drinking water for daily life, work and leisure, and is easy to accept and convenient to eat; does not inhibit appetite of people, does not need to be eaten, does not limit food calorie , People can enjoy delicious food, reduce obesity and increase nutrient substances; the health care food has the advantages that the health care food has the effects of strengthening intestines and stomach, stimulating gastric secretion of a human body, improving the activity of pepsin, promoting the digestion of food and the absorption of nutrient substances when the food containing heavy oil polysaccharide is eaten, providing energy guarantee for various activities of the human body, inhibiting the partial absorption of the human body to fat and sugar substances, inhibiting the conversion of the absorbed partial carbohydrate substances into fat, reducing the generation of new fat in the body and preventing the accumulation of fat in blood, fat tissues and visceral tissues of the human body; accelerating the consumption, metabolism, oxidation and decomposition of human fat, promoting the conversion of the human fat into energy, oxidatively decomposing and metabolizing the internal fat, supplying energy to cardiac muscle, changing waste into valuable, reducing the fat tissue of internal organs of the human body, and being beneficial to preventing or treating arteriosclerosis, lipid metabolism disorder, hypertension, coronary heart disease and blood circulation barrier diseases; promoting the proliferation of bifidobacteria in human intestinal tract, improving the flora of the intestinal tract, preventing the atrophy of the mucous membrane of the intestinal tract, promoting the absorption of nutrient elements by the intestinal tract, moistening intestines and relieving constipation and timely excreting toxins and metabolites in the body; the weight-reducing beverage can be eaten together with rice or bread and can quench thirst, is suitable for people in various lives, works and leisure, can unconsciously inhibit the absorption of fat and carbohydrate and consume the fat in the body in the lives, works and leisure to achieve the purpose of reducing weight, can enjoy delicious food, reduce obesity and increase nutrient substances so as to meet the requirements of people on various foods, and can enjoy the satisfaction, joyful feeling and happiness of people brought by various delicious foods;
the weight-reducing beverage changes the production mode of capsules, tablets and granules for weight reduction, initiates the production of the weight-reducing beverage, is easy to purchase functional raw materials, is easy to process medicinal and edible Chinese medicinal materials into extracts, and can be industrially produced in a large scale; the novel weight-losing method has the advantages that the novel weight-losing method is created, the appetite of people is not inhibited, the diet is not required, the food calorie is not limited, and the modes of sucrose-free and prebiotics are not used, the food is inhibited from being converted into fat while the food digestion and the nutrient substance absorption are promoted, the generation of new fat in the body is reduced, the fat in the body is oxidized to supply energy to the body, the waste is changed into valuable, the intestinal flora is improved, and the absorption of the nutrient substance in the intestinal tract is promoted, so that the novel weight-losing method that people can enjoy delicious food, reduce obesity and increase the nutrient substance is achieved;
1. cucumber, wax gourd, cactus, lotus leaf, polydextrose, arabinose, L-carnitine, hawthorn and endothelium corneum gigeriae galli are used for controlling the digestive tract of a human body: the fat and sugar absorption in intestinal tracts is inhibited, the generation of new fat in a human body is reduced, the accumulation of fat in blood, fat tissues and liver in the human body is prevented, the weight increase is inhibited, and the obesity is effectively prevented; secondly, gastric secretion is stimulated, pepsin activity is improved, digestion of food is promoted, and non-digested sugar enters the large intestine and is utilized by probiotics, so that proliferation of bifidobacteria is promoted, intestinal mucosa atrophy is prevented, and absorption of nutrient elements by the intestinal tract is promoted; thirdly, the partial absorption of carbohydrate is inhibited, the absorption speed of the human body to glucose is slowed down, the capability of entering the human body is reduced, the accumulation of glucose, cholesterol and fat in the human body is prevented, the fat in the human body is reduced, the blood sugar is reduced, diabetes can be prevented and treated, the increase of fat is inhibited, the accumulation of fat is inhibited, the weight is lightened, and the redundant cholesterol, fat and sugar in the human body are eliminated, so that arteriosclerosis and obesity are inhibited; fourthly, the conversion of the saccharides and the starch into heat energy is accelerated, the physiological function of the human body is maintained, and energy is supplied when various activities are carried out;
2. cucumber, wax gourd, cactus, lotus leaf, polydextrose and arabinose are used for controlling from human viscera: firstly, lipid synthesis is hindered, carbohydrate absorbed by a human body is inhibited from being converted into fat, fat accumulation in the human body is prevented due to fat synthesis inhibition, and fat tissue and weight increase is inhibited; thirdly, the visceral fat content is reduced, partial absorption of fat and sugar substances and conversion of the sugar substances into fat are inhibited, the source and synthesis of new fat in the human body are reduced, and the human body can only decompose original fat for operation, so that the fat accumulation in the human body is reduced, the fat is decomposed, the increase of the fat content in blood, fat tissues and liver is also inhibited, and the fat reserve in the human body is reduced;
3. cucumber, wax gourd, cactus, lotus leaf, polydextrose, arabinose, L-carnitine are controlled from adipose tissue: firstly, the organism converts the decomposed fat into energy, inhibits the digestion and absorption of fat and sugar, reduces the capability of entering the body, promotes the decomposition of fat and carbohydrate, accelerates the combustion of visceral fat, accelerates the conversion of the visceral fat into energy for human activities, promotes the rapid decomposition of redundant fat to supply energy to the human body, is beneficial to protecting heart and brain systems, provides operation power for the human body to engage in various activities, reduces the fat of the human body, reduces blood fat, provides a strength source for the heart and brain systems of the human body, reduces visceral fat tissues of the human body, and is beneficial to treating arteriosclerosis, lipid metabolism disorder, hypertension, coronary heart disease and blood circulation obstacle diseases; secondly, the fat consumption is enhanced, the secretion function of a human body is regulated, the activity of lipase is regulated, glucose, cholesterol and fat are digested and prevented from being accumulated in the human body, the excessive fat is promoted to be rapidly decomposed, abdominal fat is decomposed, the excretion of lipoid compounds is promoted, the body fat is reduced, the weight is reduced, water and muscle are not reduced, the cardiovascular and cerebrovascular diseases are prevented and relieved, the blood pressure is lowered, and the metabolism is promoted;
4. cucumber, wax gourd, polydextrose, arabinose and lotus leaf are used for balance control of a human body system. Firstly, the generation of the convergent fat is reduced, the digestion and absorption of sugar are inhibited, the non-digestible sugar is utilized by probiotics after entering the large intestine, the growth of bifidobacteria is promoted, a large amount of organic acid is generated, the organic acid provides the synthesis of fat, the generation of the convergent fat is reduced, the fat accumulation is reduced, and the effect of losing weight is achieved; secondly, the prebiotics for regulating the balance of intestinal flora can effectively regulate the pH value of the intestinal tract, improve the breeding environment of beneficial bacteria and rapidly expand the beneficial flora such as bifidobacterium and the like, thereby inhibiting the growth of saprophytic bacteria, preventing the atrophy of intestinal mucosa, timely excreting in-vivo toxin and metabolite, preventing the diseases such as hemorrhoids, gastroenteritis, colon cancer and the like and promoting the absorption of mineral substances by the intestinal tract; thirdly, reducing the absorption of the human body to toxic and carcinogenic substances, reducing the synthesis and absorption of choline and salts, promoting the excretion of lipid compounds, reducing the cholesterol level of the blood plasma and the liver of the human body, protecting the liver, preventing and treating hypertension, coronary arteriosclerosis and cholelithiasis, preventing cardiovascular and cerebrovascular diseases, regulating blood fat, reducing fat accumulation, preventing obesity and the like, and fourthly, relaxing the bowel, wherein dietary fibers absorb water and swell in the intestinal tract of the human body and keep moisture, increasing the volume of excrement, promoting the gastrointestinal peristalsis, playing a role in relaxing the bowel and preventing constipation, softening the stubborn stool and discharging intestinal toxins after sucrose and arabinose which are not absorbed enter the large intestine, and simultaneously protecting the liver, preventing the hypertension and the arteriosclerosis, improving the diarrhea and the constipation and accelerating the metabolism of the body;
5. the functional sugar alcohol, the fructose and the oligosaccharide are adopted to season the taste, so that the taste is improved, the functional sugar alcohol is supplemented, the proliferation of bifidobacteria in intestinal tracts of a human body is promoted, the intestinal flora is improved, the growth of saprophytic bacteria is inhibited, the atrophy of the intestinal mucosa is prevented, the absorption of nutrient substances by the intestinal tracts is promoted, in addition, in-vivo toxins and metabolites are timely excreted, and the absorption of toxic and carcinogenic substances by the human body is reduced.
Drawings
FIG. 1 is a table of the effect of compositions on weight change in mice;
FIG. 2 is a table of the effect of compositions on blood lipid changes in mice;
figure 3 is a table of the effect of composition groups on body weight in humans.
Detailed Description
In order to make the objects, technical solutions and advantages of the embodiments of the present invention clearer, the technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the drawings in the embodiments of the present invention. It is to be understood that the embodiments described are only a few embodiments of the present invention, and not all embodiments. The components of embodiments of the present invention generally described and illustrated in the figures herein may be arranged and designed in a wide variety of different configurations. Thus, the following detailed description of the embodiments of the present invention, presented in the figures, is not intended to limit the scope of the invention, as claimed, but is merely representative of selected embodiments of the invention. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
Example 1, this example discloses a diet composition beverage that inhibits the absorption of fats and carbohydrates; the composition beverage comprises the following components: 5-20 kg of cucumber, 5-20 kg of wax gourd, 1-10 kg of cactus, 1-10 kg of lotus leaf, 3-20 kg of polydextrose, 3-20 kg of arabinose, 5-25 kg of L-carnitine, 0-10 kg of hawthorn, 0-10 kg of endothelium corneum gigeriae galli, 1-20 kg of antioxidant, 1-10 kg of flavoring agent and 1-20 kg of clarifying agent.
The edible value of the raw materials of the composition of the invention is as follows:
cucumber: clearing heat, promoting diuresis, removing toxic substances, relieving swelling, promoting fluid production, quenching thirst, resisting tumor, and resisting aging; does not participate in sugar metabolism, and inhibits the conversion of saccharides into fat, thereby reducing fat in vivo, effectively promoting organism metabolism, and reducing weight; relaxing bowel, promoting the elimination of decayed substances in the intestinal tract of a human body and reducing cholesterol; the health of the heart and the brain is maintained, the memory is improved, nerve cells are protected from being damaged, the brain and the nervous system function are facilitated, the brain is invigorated, the nerve is calmed, the tension is relieved, the insomnia is treated in an auxiliary way, the inflammation of the brain is relieved, and the health of the heart is maintained; the product has effects in caring skin, moistening skin, supplementing water, whitening skin, and smoothing wrinkles; preventing alcoholism;
white gourd: inducing diuresis to alleviate edema, clearing heat, quenching thirst, and promoting diuresis; inhibiting the conversion of sugar into fat, and accelerating the conversion of sugar and starch into heat energy, thereby reducing fat in vivo and preventing the accumulation of fat in vivo; enhancing fat consumption, consuming excessive fat, reducing body cholesterol, reducing blood lipid, preventing atherosclerosis, reducing cholesterol and glyceric acid in blood, and preventing and treating coronary heart disease; relaxing bowel, coarse fibers stimulate intestinal peristalsis, and carcinogens accumulated in the intestinal tract are excreted as soon as possible; the beauty and skin moistening has the activity of inhibiting melanin deposition, is a good skin moistening and beautifying component, can make the appearance ruddy and glossy, and make the skin tender and smooth, and the hair black and glossy; detoxicate, relieve alcoholism and fish poison.
Cactus: the health-care food has the effects of resisting oxidation, strengthening spleen and stomach, promoting qi and blood circulation, clearing away heat and toxic materials, removing blood stasis and eliminating swelling, resisting oxidation, inhibiting bacteria, reducing blood fat and blood sugar, inhibiting fat absorption in intestinal tracts, promoting metabolism, eliminating redundant cholesterol, fat and sugar in a human body, avoiding excessive glucose accumulation in the human body and playing a role in reducing blood sugar, thereby inhibiting arteriosclerosis and obesity and preventing and relieving cardiovascular and cerebrovascular diseases; promoting lipolysis, regulating human body secretion function and regulating lipase activity, regulating lipase with hormone-like regulation effect, inhibiting fat synthesis in liver, digesting and preventing accumulation of glucose, cholesterol and fat in human body, promoting hydrolysis of fat tissue, promoting rapid decomposition of excessive fat, reducing fat in body and reducing weight; has effects in killing various pathogens, resisting inflammation and bacteria, relieving stomach pain, reducing blood lipid, enhancing immunity, loosening bowel to relieve constipation, clearing away heat and toxic materials.
Lotus leaf: resisting oxidation, scavenging free radicals, inhibiting bacteria, clearing summerheat, promoting diuresis, invigorating spleen, clearing yang, removing blood stasis, stopping bleeding, promoting urination, relaxing bowels, and removing intestinal toxic substances. Inhibiting fat digestion and absorption, directly discharging excessive fat in intestines without absorption, blocking excessive absorption of fat, enhancing fat consumption, preventing saccharide substance from being converted into fat, preventing fat accumulation in blood, preventing blood fat from depositing on blood vessel wall, reducing blood fat and removing oil to effectively decompose fat in vivo, enhancing human body excretion, and preventing thrombosis, thereby preventing atherosclerosis of artery, improving blood viscosity, relieving weight increase, and preventing fatty liver; improving metabolism function of organism, reducing free fatty acid, lowering glucose entering into cell for synthesizing neutral fat, and reducing fat reserves in vivo; relaxing bowels, discharging metabolite and toxin out of body in time, improving digestive tract metabolism function, invigorating spleen, eliminating dampness, reducing obesity, reducing blood lipid, and lowering blood sugar.
Polydextrose: regulating lipid metabolism, inhibiting the absorption of carbohydrate by intestinal tract, inhibiting the absorption of fat by human body, promoting lipid metabolism, preventing food from fully contacting digestive juice, inhibiting the secretion of incretin, slowing down the absorption rate of glucose by human body, fully playing the role of insulin, lowering blood sugar level, reducing the synthesis and absorption of choline and salts, promoting the excretion of lipid compounds, lowering the levels of plasma and liver cholesterol of human body, preventing and treating coronary arteriosclerosis and cholelithiasis, preventing cardiovascular and cerebrovascular diseases, lowering blood fat and blood sugar, reducing fat accumulation, preventing obesity, etc.; the water-soluble dietary fiber can absorb water and swell in the intestinal tract of a human body and keep water, improves the gastrointestinal tract, promotes defecation, eliminates constipation, relieves poisoning and diarrhea caused by harmful substances, and plays a role in relaxing bowel and preventing constipation; reducing cholesterol, reducing synthesis and absorption of cholic acid and salts, reducing cholesterol in blood and liver, preventing and treating coronary arteriosclerosis and cholelithiasis, and preventing cardiovascular disease and cerebrovascular disease; the probiotic has the effects of regulating prebiotics for balancing intestinal flora, effectively regulating the pH value of the intestinal tract, improving the propagation environment of beneficial bacteria and effectively promoting the proliferation of bifidobacteria, thereby inhibiting the growth of saprophytic bacteria, reducing the absorption of toxic and carcinogenic substances by human bodies, timely excreting toxins and metabolites in the bodies, avoiding the discharge of toxins from the skin, achieving the effects of beautifying the skin and keeping young, preventing diseases such as hemorrhoids, gastroenteritis, colon cancer and the like, preventing atrophy of intestinal mucosa, promoting the absorption of nutrient substances, resisting infection and preventing the occurrence of intestinal diseases and cancers.
Arabinose: inhibiting digestion and absorption of saccharides, inhibiting metabolism and absorption, inhibiting enzyme hydrolyzing disaccharide, lowering blood sugar, inhibiting liver synthesis fat, inhibiting digestion and absorption of sugar, reducing capability of entering into body, reducing fat into body by decomposing fat, reducing abdominal fat growth, preventing accumulation, and lowering blood sugar; the probiotics function, the indigestible sugar is utilized by the probiotics after entering the large intestine, the growth of bifidobacteria is promoted, the intestinal environment is optimized, a large amount of organic acid is generated, the organic acid provides the synthesis of fat, the generation of convergent fat is reduced, the fat accumulation is reduced, and the effect of losing weight is achieved; relaxing bowels and removing toxic substances, wherein sucrose and arabinose which are not absorbed enter large intestine to soften stubborn stool, discharge enterotoxin, protect liver and kidney, prevent hypertension and arteriosclerosis, improve skeletal muscle fiber components, decompose fat, and improve diarrhea and constipation; it has been reported that the addition of 3.5% L-arabinose to sucrose inhibits the absorption of 60-70% sucrose by the human body, and also increases the blood glucose level by about 50% less.
L-carnitine: the fat is oxidized into energy, the activity of respiratory enzymes in mitochondria is changed, the oxidation function of a human body is improved, free fatty acid enters a carrier of mitochondria, the fatty acid is promoted to enter the mitochondria, a large amount of fat participates in the oxidation process, the consumption of glycogen can be reduced, the oxidation speed of fat is improved to become energy, the aerobic capacity is further improved, the myocardial energy is derived from the oxidation of the fatty acid and is used as an important nutrient substance of myocardium, the myocardial energy is enhanced, the cardiac function is improved, the cardiac blood output is increased, the heart and blood vessels are obviously protected, the absorption of the fat is inhibited, and the combustion of the fat in the body can be promoted in motion to provide the energy so as to reduce the fat accumulation; cleaning blood vessel garbage, accelerating fat consumption, improving high density lipoprotein level in blood, helping to remove cholesterol in vivo, reducing blood lipid, protecting blood vessel, and lowering blood pressure; the antioxidant can also remove free radicals and protect the stability of cell membranes; resisting fatigue, inhibiting lactic acid generation, accelerating elimination of lactic acid accumulated in exercise, improving duration of anaerobic exercise, promoting urea circulation, improving exercise ability, and promoting recovery of exercise-induced fatigue.
Hawthorn fruit: the stomach-invigorating and digestion-promoting health food has the effects of tonifying spleen, stimulating appetite, promoting digestion, helping digestion, stimulating gastric secretion, improving pepsin activity, promoting digestion of protein and fat, regulating gastrointestinal functions, treating food retention, gastral cavity fullness, reducing blood fat, resisting atherosclerosis, resisting myocardial ischemia, enhancing myocardial contractility, increasing cardiac output, lowering blood pressure, promoting blood circulation, eliminating phlegm, resisting oxidation, accelerating gastric emptying rate, solving the problem of food accumulation and indigestion after eating, promoting digestive absorption of food, and enhancing the supply of nutrient substances.
Endothelium corneum gigeriae galli: the food has the effects of removing food retention, strengthening the spleen and stomach, promoting gastric secretion, acidity and digestive ability, promoting the enhancement of gastric motility, treating food retention and fullness, vomiting, regurgitation, malnutritional stagnation, diabetes and accelerating the evacuation rate of the stomach, has stronger functions of promoting digestion and removing food retention, solves the problem that food is accumulated in the stomach and can not be retained after eating, promotes the digestion and absorption of food, and enhances the supply of nutrient substances.
Antioxidant:
glutathione: the antioxidant effect is involved in various important biochemical reactions of an organism, protects important enzyme protein sulfydryl in the body from being oxidized and inactivated, ensures energy metabolism and cell utilization, effectively removes free radicals of the human body, improves the immunity of the human body, and activates various enzymes, thereby promoting the metabolism of sugar, fat and protein, maintaining the stability of a red blood cell membrane structure, eliminating the damage effect of an oxidant on the red blood cell membrane structure, protecting hemoglobin from being oxidized by hydrogen peroxide and free radicals, preventing the red blood cell from being hemolyzed to cause hyperferrierythroproteinemia, further ensuring that the red blood cell can continuously and normally exert the oxygen transport capacity, eliminating the free radicals in the human body, cleaning and purifying the environmental pollution in the human body, and further improving the physical and mental health of the human body; integrates the detoxification function, eliminates toxic substances in the body, and glutathione can be combined with toxic compounds, heavy metal ions or carcinogenic substances, aflatoxin and the like entering the human body, so as to weaken or eliminate the toxic effect, promote the toxic compounds to be discharged out of the body, play a role in neutralizing and detoxifying, and help to maintain the normal immune system function. The liver-protecting function and the liver cell function are protected, the liver-protecting tea is used for liver cell damage caused by various reasons, the resistance of organisms to adverse environment is improved, the liver-protecting tea participates in the metabolism of chemical substances such as hormone, medicaments, endogenous and exogenous toxics and the like, the synthesis function of the liver is promoted, the loss of glycine and taurine in liver diseases is supplemented, the fat metabolism and the absorption of fat-soluble vitamins are improved, the liver-protecting tea has good recovery effect on diseases such as alcoholic liver diseases, liver damage, liver cirrhosis, chronic glomerulonephritis and the like, and the inflammatory index of a patient can be obviously reduced. Can help to maintain the function of normal immune system, has antioxidation and integration and decomposition interaction effects, can improve the efficacy by combining with vitamin C, and can inhibit the fatty liver generated by ethanol invading the liver; antibacterial and antiviral effects, and can be used as food additive and stabilizer; promote carbohydrate, fat and protein metabolism; can participate in various important biochemical reactions of organisms, protects important enzyme protein sulfydryl in the organisms from being oxidized and inactivated, ensures energy metabolism and cell utilization, and simultaneously can directly reduce free radicals into acidic substances by combining the sulfydryl with free radicals in the organisms so as to accelerate the excretion of the free radicals and resist the damage of the free radicals to important organs; has antiallergic effect, and can prevent skin aging and pigmentation, reduce melanin formation, improve skin oxidation resistance and luster skin.
Apple polyphenol: the product has the functions of resisting oxidation, deodorizing, preserving freshness, keeping fragrance, protecting color, preventing loss of vitamins and the like, can prevent deterioration of food quality, can obviously improve the product quality and shelf life, can prevent dental caries, hypertension, anaphylactic reaction, tumor, mutation, ultraviolet absorption and other physiological functions, can enhance muscle strength, resist aging, radiation and halitosis, is anti-whitening and moisture-preserving, can be used as clear juice of wines and beverages, resists oxidation, removes free radicals in vivo, prolongs the storage life of the food, improves the quality of the food, and increases the added value of the food.
Vitamin C: the fragility of capillary vessels is reduced, the anti-stress capability and the fatigue-free capability of an organism to the external environment are enhanced, the integrity of the blood vessels is maintained, the cell metabolism is promoted, the detoxification of cells is facilitated, the formation of antibodies is facilitated, and the anti-oxidation and anti-free radical capability is realized; promoting iron absorption, carbohydrate utilization, fat and protein synthesis, improving fat and lipid especially cholesterol metabolism, preventing cardiovascular diseases, resisting stress and immunity, maintaining immunity, whitening skin, and removing speckle; promoting the formation of antibodies, promoting the absorption of iron, detoxifying and relieving the toxic action of heavy metals such as lead, mercury, cadmium, arsenic and the like on organisms; preventing cancer; a food preservative.
Tea polyphenol: inhibiting nitrite, expelling lactic acid, refreshing; antioxidant, food preservative, color retention agent, food deodorant, blood lipid regulating, antiviral, antibacterial, antioxidant, free radicals scavenging, cell membrane structure protecting, antiaging, life prolonging, wrinkle preventing, speckle removing, acne preventing, edema preventing and antiallergic effects.
The pharmacological mechanism of the composition of the invention is as follows: promoting digestion of food and absorption of nutrient substances, inhibiting absorption of saccharides and fat, inhibiting fat synthesis, promoting fat decomposition, accelerating fat metabolism, and regulating intestinal flora, and has the action mechanism of preventing partial absorption of fat and saccharide substances, inhibiting conversion of saccharides into fat, reducing generation of new fat in human body, and preventing accumulation of fat in human body; blocking lipid synthesis, inhibiting adipose tissue and body weight gain due to fat synthesis blocking; regulating lipase activity, decomposing fat effectively, promoting decomposition of excessive fat, promoting fat oxidation, accelerating fat consumption, and burning visceral fat; promoting fat metabolism, inhibiting increase of fat content in blood, adipose tissue and liver, inhibiting weight increase, and effectively preventing obesity; promoting digestion and absorption of food, regulating intestinal flora, improving intestinal microbial environment, promoting proliferation of Bifidobacterium in intestinal tract, inhibiting growth of saprophytic bacteria, preventing atrophy of intestinal mucosa, promoting absorption of nutrients, and timely discharging toxin and metabolite in vivo to achieve the purpose of reducing weight. After people eat the composition, the appetite is not inhibited, the diet is not needed, the food calorie is not limited, the partial absorption of fat and sugar substances is inhibited, the conversion of the sugar substances into fat is inhibited, the heavy oil polysaccharide food is eaten as long as people want to eat, various delicious foods are enjoyed, and the absorption of nutrient substances is promoted; the new fat source in the human body is reduced, the fat metabolism is accelerated, the decomposition of the fat is promoted to supply energy to human tissue cells, the running power is provided, the combustion of visceral fat is accelerated, and the purpose of losing weight is achieved; a weight-reducing beverage, can be eaten together with rice or bread and quench one's thirst, is suitable for all kinds of life, work and leisure crowd to drink, has developed a weight-reducing beverage for all kinds of crowds, people unconsciously inhibit the absorption of fat, carbohydrate material and consume the internal fat in life, work and leisure, reduce the adipose tissue in the human body, people can enjoy the delicious food and can reduce obesity and can increase the nutritive material, in order to satisfy people's demand to all kinds of food, enjoy all kinds of delicious food and bring people's joyful sense, satisfaction and happiness.
The embodiment is further configured as follows: the flavoring agent is one or more of erythritol, maltitol, malto-oligosaccharide, soybean oligosaccharide, trehalose, mannitol, cinnamon, L-potassium malate, fructose and alanine.
The embodiment is further configured as follows: the clarifying agent is one or more of herba Zosterae Marinae extract and papain.
The embodiment is further configured as follows: the cucumber, wax gourd, cactus, lotus leaf, hawthorn, endothelium corneum gigeriae galli, kelp and cinnamon are respectively cucumber extract, wax gourd extract, cactus extract, lotus leaf extract, hawthorn extract, endothelium corneum gigeriae galli extract, kelp extract and cinnamon extract.
The embodiment is further configured as follows: the antioxidant is a mixture of glutathione, apple polyphenol, vitamin C and tea polyphenol, and the weight ratio of the antioxidant to the antioxidant is 1:1 of 8230and 1 of the above-mentioned raw materials.
The embodiment is further configured as follows: the composition beverage can be used in food, health product, and pharmaceutical dosage forms, and can also be made into capsule, tablet or granule.
The embodiment is further configured as follows: the preparation method of the cucumber extract, the wax gourd extract, the cactus extract, the lotus leaf extract, the hawthorn extract, the endothelium corneum gigeriae galli extract, the kelp extract and the cinnamon extract comprises the following steps:
step 1, preparing raw materials: cucumber, wax gourd, lotus leaf, cactus, kelp, hawthorn, endothelium corneum gigeriae galli and cinnamon;
step 2, crushing: manually sorting the collected Chinese medicinal raw materials according to varieties, putting into a washing tank, drying to constant weight, crushing to obtain fine powder of the Chinese medicinal raw materials, and sieving by more than 150-200 meshes;
step 3, extraction: conveying the fine powder of the edible and medicinal materials to an extraction tank, adding purified water, material water 1: 5. keeping the temperature at 65-95 ℃ for 1-3 hours and 3 times, centrifugally separating to obtain supernatant and medicinal fine powder residues, and inputting the supernatant into an alcohol precipitation tank for precipitation;
inputting the fine powder slag of the edible and medicinal materials into an extraction tank, and adding purified water, material water 1:5, PH4.5-6.0, adding pectinase and cellulase, keeping the temperature at 40-45 ℃ for 2-3 hours and 2 times, centrifugally separating to obtain supernatant and medicinal fine powder residues, and inputting the supernatant into an alcohol precipitation tank for precipitation;
inputting the fine powder slag of the edible and medicinal materials into an extraction tank, and adding purified water, material water 1: 3. adding neutral protease at the pH of 6.5-8.0, keeping the temperature at 25-35 ℃ for 2 times for 2-3 hours, centrifuging to obtain supernatant, and inputting the supernatant into an alcohol precipitation tank for precipitation;
step 4, purification: and (4) concentrating the supernatant precipitated in the alcohol precipitation tank in the step (3) under reduced pressure to 50% of the volume, decoloring, and then performing alcohol precipitation, washing, vacuum drying, dissolving, removing impurities by using an ultrafiltration membrane, and vacuum drying to obtain a finished product of the extract for later use.
A preparation method of a weight-losing composition beverage for inhibiting the absorption of fat and sugar substances comprises the following steps:
s1, preparing raw materials: 5-20 kg of cucumber, 5-20 kg of wax gourd, 1-10 kg of cactus, 1-10 kg of lotus leaf, 3-20 kg of polydextrose, 3-20 kg of arabinose, 5-25 kg of L-carnitine, 0-10 kg of hawthorn, 0-10 kg of endothelium corneum gigeriae galli, 1-20 kg of antioxidant, 1-10 kg of flavoring agent and 1-20 kg of clarifying agent;
the cucumber, the polydextrose and the arabinose are dry-mixed uniformly to form a material A; mixing radix et caulis Opuntiae Dillenii, L-carnitine, fructus crataegi and folium Nelumbinis, and making into No. B material; mixing fructus Benincasae, endothelium corneum Gigeriae Galli, and antioxidant, and making into No. C material;
s2, preparing materials: conveying purified water to a batching tank through a pipeline, heating to 30-40 ℃, then conveying the material A, the material B and the material C obtained in the step S1 to the batching tank in sequence through pipelines, starting stirring, stirring at a low speed for 10-20 min, dissolving and mixing the material liquid in the batching tank uniformly, and starting a filter to remove impurities;
s3, seasoning: cooling and conveying the material obtained in the step S2 to a quantifying tank, adding purified water for complementing, heating to 30-40 ℃, adding a flavoring agent for dissolving, stirring at a low speed until the mixture is uniformly mixed, and opening a filter to remove impurities;
s4, clarification: adding a clarifying agent into the feed liquid obtained in the step S3 until the feed liquid is dissolved, stirring at a low speed for 5-10 min, heating to 100 ℃, keeping the temperature constant for 5-10 min, cooling to 0 ℃, keeping the temperature constant for 10-20 min, opening a filter to remove impurities, and conveying to an aseptic storage tank;
s5, sterile subpackaging: and (4) subpackaging the stock solution obtained in the step (S4), connecting the stock solution of an aseptic storage tank with a canning machine through a pipeline, performing aseptic subpackaging to obtain a finished product, and boxing.
And S6, checking.
Experimental examples of fat-reducing composition beverage for inhibiting absorption of fat and sugar-containing substances:
1. effects of the composition on mouse body weight and blood lipid changes;
1.1 mice, weight loss compositions, foods, metering tools, instruments, dissecting instruments, and the like;
1.2 selecting 30 mice with similar body weight, wherein the male and female parts are respectively provided with a basic group, a control group and a composition dosage group;
1.3A basic feed: 20% of barley flour, 10% of dehydrated vegetables, 20% of bean flour, 1% of yeast, 5% of bone meal, 16% of corn flour, 16% of bran, 10% of fish meal and 2% of salt.
1.31B nutritious feed: every 100g of basal feed is added with 10g of milk powder, 10g of lard oil, 10g of colza oil, 5g of peanut oil, 10g of sugar, 1 egg, 10 drops of cod liver oil and 250g of fresh soybean sprouts.
1.32C composition dose group feed: converting the composition beverage into dry matter, converting into mouse weight dosage according to adult (65 kg body weight), and making into granule with B nutritional feed;
1.4 basic groups: administering 15g of basal feed A to mice every day for 3 times, wherein the basal feed A is supplied according to 5g every time and is not added after eating for 90 days continuously;
1.41 control group: the nutritional feed B is given to the mice 15g every day, 3 times, 5g every time, and no addition is needed after eating for 90 days continuously;
1.42 composition dose groups: the feed of the C composition dose group of the mice is 15g every day and is supplied for 3 times, and the feed is not added after the mice are eaten for 90 days continuously;
1.5 weighing and recording the weight of the mice, extracting blood of each group of mice, picking up organs of each group of mice, and measuring the blood fat of the mice;
1.6 data processing and result determination.
As shown in fig. 1, the experimental results show that: the weight of the mice in the basal group is increased by 5.89g in 90 days, the weight of the mice in the control group is increased by 13.96g in 90 days, and the weight of the mice in the composition dosage group is reduced by 1.85g in 90 days, which indicates that the composition dosage group has obvious weight-reducing effect.
As shown in fig. 2, the experimental conclusion is: the indexes of triglyceride, serum total cholesterol and serum high-density lipoprotein of a control group mouse are obviously higher than those of a basic group and a composition dosage group, and the indexes of triglyceride, serum total cholesterol and serum high-density lipoprotein of a composition dosage group mouse are obviously lower than those of the control group and the basic group, so that the composition dosage group has obvious effects of oxidizing and decomposing human fat and reducing the fat in blood to achieve the purpose of losing weight.
2. Human body test feeding experiment;
2.1 weight loss composition beverages, foods, metering tools, etc.;
2.2 the number of the tested people is 20, and the tested people are half of the number of the tested people, and are randomly divided into a control group and a composition dosage group;
2.21 control group: randomly distributing 10 persons, half each man and half each woman, increasing 100g (half fat and half lean) meat food amount on the basis of ordinary food every day, not administering the composition, and continuously taking for 90 days;
2.22 composition dose groups: randomly distributing 10 people, half each man and half each woman, increasing 100g (half fat and half lean) meat food amount every day on the basis of ordinary food, and administering the edible composition beverage for 90 days;
2.3 weighing and recording the weight of the tested person;
2.4 data processing and result determination.
As shown in FIG. 3, the control group was increased by 4.27kg and the composition dose group was decreased by 1.84kg, indicating that the composition dose group had significant inhibitory effect on fats and sugar foods and reduced body weight in humans.
Claims (8)
1. A weight-reducing composition beverage for inhibiting the absorption of fat and sugar substances, which is characterized in that:
the composition beverage comprises the following components: 5-20 kg of cucumber, 5-20 kg of wax gourd, 1-10 kg of cactus, 1-10 kg of lotus leaf, 3-20 kg of polydextrose, 3-20 kg of arabinose, 5-25 kg of L-carnitine, 0-10 kg of hawthorn, 0-10 kg of endothelium corneum gigeriae galli, 1-20 kg of antioxidant, 1-10 kg of flavoring agent and 1-20 kg of clarifying agent.
2. The fat-reducing composition beverage for inhibiting the absorption of fats and carbohydrates according to claim 1 wherein: the flavoring agent is one or more of erythritol, maltitol, malto-oligosaccharide, soybean oligosaccharide, trehalose, mannitol, cinnamon, L-potassium malate, fructose and alanine.
3. The fat reducing composition beverage for inhibiting the absorption of fats and sugar according to claim 2, wherein: the clarifying agent is one or more of herba Zosterae Marinae and papain.
4. The fat reducing composition beverage for inhibiting the absorption of fats and carbohydrates as claimed in claim 3 wherein: the cucumber, wax gourd, cactus, lotus leaf, hawthorn, endothelium corneum gigeriae galli, kelp and cinnamon are respectively cucumber extract, wax gourd extract, cactus extract, lotus leaf extract, hawthorn extract, endothelium corneum gigeriae galli extract, kelp extract and cinnamon extract.
5. The fat-reducing composition beverage for inhibiting the absorption of fats and carbohydrates according to claim 1 wherein: the antioxidant is a mixture of glutathione, apple polyphenol, vitamin C and tea polyphenol, and the weight ratio of the antioxidant to the antioxidant is 1:1 of 8230301.
6. The fat-reducing composition beverage for inhibiting the absorption of fats and carbohydrates according to claim 1 wherein: the composition beverage can be used in food, health product, and pharmaceutical preparation.
7. The weight-loss composition beverage for inhibiting the absorption of fats and sugar substances according to claim 4, wherein the preparation method of the cucumber extract, the wax gourd extract, the cactus extract, the lotus leaf extract, the hawthorn extract, the endothelium corneum gigeriae galli extract, the kelp extract and the cinnamon extract is as follows:
step 1, preparing raw materials: cucumber, wax gourd, lotus leaf, cactus, kelp, hawthorn, chicken's gizzard-membrane and cinnamon;
step 2, crushing: manually sorting the collected edible and medicinal raw materials according to varieties, putting into a washing machine, drying to constant weight, crushing to obtain edible and medicinal fine powder, and sieving by more than 150-200 meshes;
step 3, extraction: conveying the fine powder of the edible and medicinal materials to an extraction tank, adding purified water, and mixing the materials with water 1: 5. keeping the temperature at 65 to 95 ℃ for 1 to 3 hours and 3 times, centrifuging and separating to obtain supernatant and medicinal and edible fine powder residues, and inputting the supernatant into an alcohol precipitation tank for precipitation;
inputting the fine powder slag of the edible and medicinal materials into an extraction tank, and adding purified water, material water 1:5, PH4.5 to 6.0, adding pectinase and cellulase, keeping the temperature at 40 to 45 ℃ for 2 to 3 hours and 2 times, centrifugally separating to obtain supernatant and medicinal fine powder residues, and inputting the supernatant into an alcohol precipitation tank for precipitation;
inputting the fine powder dregs of the edible and medicinal materials into an extraction tank, and adding purified water, material water 1: 3. adding neutral protease at the pH of 6.5-8.0, keeping the temperature at 25-35 ℃ for 2 times for 2-3 hours, centrifuging to obtain supernatant, and inputting the supernatant into an alcohol precipitation tank for precipitation;
and 4, purifying: and (3) concentrating the supernatant precipitated in the alcohol precipitation tank in the step (3) to 50% of the volume under reduced pressure, decoloring, performing alcohol precipitation, washing, vacuum drying, dissolving, removing impurities by using an ultrafiltration membrane, and vacuum drying to obtain an extract finished product for later use.
8. The method for preparing fat and sugar absorption inhibiting slimming composition beverage according to any one of claims 1 to 7, characterized in that the preparation method comprises the steps of:
s1, preparing raw materials: 5-20 kg of cucumber, 5-20 kg of wax gourd, 1-10 kg of cactus, 1-10 kg of lotus leaf, 3-20 kg of polydextrose, 3-20 kg of arabinose, 5-25 kg of L-carnitine, 0-10 kg of hawthorn, 0-10 kg of endothelium corneum gigeriae galli, 1-20 kg of antioxidant, 1-10 kg of flavoring agent and 1-20 kg of clarifying agent;
uniformly dry-mixing cucumber, polydextrose and arabinose to obtain a material A; uniformly mixing cactus, L-carnitine, hawthorn and lotus leaves in a dry mode to obtain a material B; mixing fructus Benincasae, endothelium corneum Gigeriae Galli, and antioxidant, and making into No. C material;
s2, preparing materials: conveying purified water to a mixing tank through a pipeline, heating to 30-40 ℃, then conveying the material A, the material B and the material C obtained in the step S1 to the mixing tank through pipelines in sequence, starting stirring, stirring at a low speed for 10-20 min, dissolving and mixing the material liquid in the mixing tank uniformly, and starting a filter to remove impurities;
s3, seasoning: cooling and conveying the material obtained in the step S2 to a quantifying tank, adding purified water for complementing, heating to 30-40 ℃, adding a flavoring agent for dissolving, stirring at a low speed until the mixture is uniformly mixed, and opening a filter to remove impurities;
s4, clarification: adding a clarifying agent into the feed liquid obtained in the step S3 until the feed liquid is dissolved, stirring at a low speed for 5-10 min, heating to 100 ℃, keeping the temperature for 5-10min, cooling to 0 ℃, keeping the temperature for 10-20min, starting a filter to remove impurities, and conveying to an aseptic storage tank;
s5, sterile subpackaging: subpackaging the stock solution obtained in the step 4, connecting the stock solution of an aseptic storage tank with a canning machine through a pipeline, carrying out aseptic subpackage to obtain a finished product, and boxing;
and S6, checking.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211195423.4A CN115553406A (en) | 2022-09-29 | 2022-09-29 | Weight-reducing composition beverage for inhibiting absorption of fat and sugar substances and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211195423.4A CN115553406A (en) | 2022-09-29 | 2022-09-29 | Weight-reducing composition beverage for inhibiting absorption of fat and sugar substances and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN115553406A true CN115553406A (en) | 2023-01-03 |
Family
ID=84742858
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211195423.4A Withdrawn CN115553406A (en) | 2022-09-29 | 2022-09-29 | Weight-reducing composition beverage for inhibiting absorption of fat and sugar substances and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115553406A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117298141A (en) * | 2023-11-24 | 2023-12-29 | 青岛市畜牧工作站(青岛市畜牧兽医研究所) | Application of polysaccharide in reducing chicken abdomen fat deposition |
-
2022
- 2022-09-29 CN CN202211195423.4A patent/CN115553406A/en not_active Withdrawn
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117298141A (en) * | 2023-11-24 | 2023-12-29 | 青岛市畜牧工作站(青岛市畜牧兽医研究所) | Application of polysaccharide in reducing chicken abdomen fat deposition |
CN117298141B (en) * | 2023-11-24 | 2024-04-05 | 青岛市畜牧工作站(青岛市畜牧兽医研究所) | Application of polysaccharide in reducing chicken abdomen fat deposition |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107156623A (en) | A kind of composite cereal mixture and preparation method thereof | |
CN102813120B (en) | Anti-cancer sea cucumber sugar-reducing flour and preparation method thereof | |
CN102144748A (en) | Five-color flour food with functions of excreting toxins, protecting liver and maintaining beauty | |
CN108719984B (en) | Meal replacement nutrition bar for gout population and preparation method thereof | |
CN104799317B (en) | Sweet potato biscuit and preparation method thereof | |
CN105815514A (en) | Weight-losing quinoa milk tea | |
CN111480851A (en) | Intestinal tract exclusive active polypeptide composition for improving human body circulation | |
CN106721855A (en) | A kind of solid beverage preparation method for safeguarding men's health | |
CN105918387A (en) | Healthcare food suitable for middle aged and elderly people and preparation method thereof | |
KR101722481B1 (en) | functional cereal containing sweet potato chip, broccoli granule and dietary fiber for constipation improving and manufacturing method thereof | |
CN106418501A (en) | Healthcare food with weight reducing function | |
CN115736142A (en) | Formula and preparation process of prebiotics prune fiber fruit drink | |
CN104814407A (en) | Nutrition powder based on sweet potatoes and preparation method of nutrition powder | |
CN107223792A (en) | Broiler chicken feed additive and its preparation method and application | |
CN115553406A (en) | Weight-reducing composition beverage for inhibiting absorption of fat and sugar substances and preparation method thereof | |
CN105707378A (en) | Black-highland barley coffee with effect of slimming | |
CN109730222A (en) | Ferment complex liquid and its health drink | |
CN109527577A (en) | A kind of composition with sobering up and liver protecting functions | |
CN109303115A (en) | Raw ketone weight losing meal-replacing milk shake | |
CN108936265A (en) | A kind of nutritional meal replacement and its preparation method and application of dark hair brighten the hair | |
CN109043259A (en) | A kind of ferment L-arabinose stachyose composite beverage underflow | |
CN115211508A (en) | Enzyme beverage and preparation method thereof | |
CN104509915A (en) | Preparation method of tomato vinegar | |
CN113842452A (en) | Medicine composition for treating diabetes and preparation method thereof | |
CN114191515A (en) | Oral gel for dispelling dampness, invigorating stomach and improving immunity and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20230103 |
|
WW01 | Invention patent application withdrawn after publication |